USA / 5 Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
USA
USA / 2 Things the Biden Administration can do Now to Lower Costs at the Pharmacy
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why biopharmaceutical companies support changes to the system that can lower…
USA / NORD Chief Strategy Officer on Health Equity's Vital Importance for Rare Disease Patients
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…